Navigating the World of Biosimilar User Fees- June 10, 2019
Published 2020-02-06Download video
Recommendations
-
24:07 Panel on Financial Incentives for CDER Medical Products - PDUFA & Biosimilars - June 10, 2019
-
7:13:56 REdI Annual Conference 2024: CDER (Drugs) Innovation in Medical Product Development (Day 2 of 2)
-
05:27 10 More Facts about What FDA Does and Does Not Approve | #FDAFacts 11-20
-
1:31:19 4th Annual National Black Family Cancer Awareness, Engaging the Generations, #BlackFamCan
-
04:01 FDA D.I.S.C.O. Burst Edition: FDA approval of Ojemda (tovorafenib) for relapsed or refractory ped...
-
56:21 FSMA Final Rule on Pre-Harvest Agricultural Water
-
6:04:12 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 1 of 2)
-
05:28 Episode 5 - On The Road with Jim Jones - April 2024
-
01:31 Contact Lenses: Safe Use of Hydrogen Peroxide Solution
-
7:00:43 185th Meeting of Vaccines and Related Biological Products Advisory Committee
-
01:00 Contact Lenses: Safe Use of Hydrogen Peroxide Solution #shorts
-
7:42:03 REdI Annual Conference 2024: CBER (Biologics) Innovation in Medical Product Development (Day 2 of 2)
-
1:12:24 Strategies to Increase Clinical Trial Participation for Diverse Communities: OMHHE REACH Consortium
-
00:17 Can Cardiac "Organ on a Chip" Technology Help Drug Toxicology Researchers? (Full Video on Channel)
-
00:31 Let's shed some light on sunscreen!
-
02:04 Opioid Use Disorder, New Biosimilar, Black Family Cancer Awareness Week, & more | In Your Day Ep. 6
-
01:06 Dr. Califf on FDA’s Medications for Opioid Use Disorder Campaign: Prescribe with Confidence
-
6:52:20 REdI Annual Conference 2024: CDRH (Devices) Innovation in Medical Product Development (Day 2 of 2)
-
23:33 LACF and Acidified Foods Regulations and Requirements
-
7:26:41 June 10, 2024 Meeting of the Peripheral and Central Nervous System Drugs Advisory Committee (PCNS)
Similar videos
-
47:50 Prescription Drug User Fee Act Waivers, Exemptions, and Refunds -Oh My- June 10, 2019
-
16:06 Data Quality Expectations for Biosimilars with Case Studies (29of33) Quality – Oct. 16-17, 2019
-
42:43 Regulatory Highlights for Biosimilars and Interchangeables (9of15) REdI – May 29-30, 2019
-
57:06 How Originator Companies Face Up to the Biosimilar Challenge Webinar Recording
-
00:37 Biosimilars Can Reduce Cost and Unlock Access to Safe and Effective Medicines
-
01:21 Dr. Denes Discusses Biosimilar Pricing in Oncology
-
1:35:09 Ebola Survivor - Dr. Ian Crozier
-
59:34 FDA Lecture: Advancing the Science of Patient Input in the Regulatory Settings
-
7:42:41 FDA Regulatory Education for Industry (REdI) Annual Conference 2023 – Plenary + Drugs Day 1
-
53:50 GCCA's 2020 Colorectal Cancer Congress -Biosimilars 101: A Fireside Chat
-
1:02:42 Regulatory Education for Industry (REdI) Annual Conference 2022 - Day 1 - Part 2
-
13:23 Equity Top Down Analysis in Bloomberg
-
41:30 Meetings: Pre-submission and Special Programs (4of15) REdI Annual Conference – May 29-30, 2019
-
2:36:05 Priced Out of a Lifesaving Drug: The Human Impact of Rising Insulin Costs
-
1:12:37 IPPCR: FDA Product Regulation
-
3:12:20 Health Hearing on Examining the Drug Supply Chain (12/13/2017)
-
36:15 Sarah Yim: Intro to Expanded Access
-
54:15 FDA Oversight of Tobacco Product Investigations – ITP or IND?
-
36:45 Cypress University 2015: Managing Prescription Drug Costs in an Explosive Rx Environment (CB306)